{
    "id": "dbpedia_1854_1",
    "rank": 59,
    "data": {
        "url": "https://www.biorxiv.org/content/10.1101/2022.03.15.484542v1",
        "read_more_link": "",
        "language": "en",
        "title": "Omicron BA.1 and BA.2 neutralizing activity elicited by a comprehensive panel of human vaccines",
        "top_image": "https://www.biorxiv.org/sites/default/files/images/biorxiv_logo_homepage7-5-small.png",
        "meta_img": "https://www.biorxiv.org/sites/default/files/images/biorxiv_logo_homepage7-5-small.png",
        "images": [
            "https://www.biorxiv.org/sites/default/files/biorxiv_article.jpg",
            "https://www.biorxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif",
            "https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/twitter.png",
            "https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png",
            "https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png",
            "https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [
            "Davide Corti",
            "Jorge Geffner",
            "Renata Grifantini",
            "Helen Y. Chu",
            "David Veesler",
            "John E. Bowen",
            "Kaitlin R. Sprouse",
            "Alexandra C. Walls",
            "Ignacio G. Mazzitelli",
            "Jennifer K. Logue"
        ],
        "publish_date": "2022-03-15T00:00:00",
        "summary": "",
        "meta_description": "bioRxiv - the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution",
        "meta_lang": "en",
        "meta_favicon": "https://www.biorxiv.org/sites/default/files/images/favicon.ico",
        "meta_site_name": "bioRxiv",
        "canonical_link": "https://www.biorxiv.org/content/10.1101/2022.03.15.484542v1",
        "text": "Competing Interest Statement\n\nD.C is an employee of Vir Biotechnology Inc. and may hold shares in Vir Biotechnology Inc. A.C.W and D.V. are named as inventors on patent applications filed by the University of Washington for SARS-CoV-2 and sarbecovirus receptor-binding domain nanoparticle vaccines. The Veesler laboratory has received a sponsored research agreement from Vir Biotechnology Inc. HYC reported consulting with Ellume, Pfizer, The Bill and Melinda Gates Foundation, Glaxo Smith Kline, and Merck. She has received research funding from Emergent Ventures, Gates Ventures, Sanofi Pasteur, The Bill and Melinda Gates Foundation, and support and reagents from Ellume and Cepheid outside of the submitted work. A.S. is a consultant for Gritstone Bio, Flow Pharma, ImmunoScape, Avalia, Moderna, Fortress, Repertoire, Gerson Lehrman Group, RiverVest, MedaCorp, and Guggenheim. SC has consulted for GSK, JP Morgan, Citi, Morgan Stanley, Avalia NZ, Nutcracker Therapeutics, University of California, California State Universities, United Airlines, Adagio, and Roche. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."
    }
}